CD209

Across TCGA cell cohorts, CD209 RNA expression is significantly associated with the go_rna of many other GO terms, with 657 significant associations in total. BLOOD_Leukemia shows the largest number of these associations.

The most reproducible CD209-associated GO terms across cancer lineages are Antibody-dependent cellular cytotoxicity, Type IIa hypersensitivity, and Type II hypersensitivity. Each is linked with CD209 in more than 2 cancer types. Because this analysis shows association rather than direction, both CD209-to-partner and partner-to-CD209 results are reported.

Each partner links to its own Q-omics profile. The box plot shows the strongest example, Antibody-dependent cellular cytotoxicity grouped by CD209-low versus CD209-high in SKIN.

RNA expression associated GO terms by consensus

Ranked by combined sampling and lineage consensus. X-score (CD209→partner) and Y-score (partner→CD209) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.

Lineage	Partner GO term	X-score	Y-score	p(X)	p(Y)	Sampling consensus	Lineage consensus
SKIN	Antibody-dependent cellular cytotoxicity →	+0.780	+0.009	.002	.003	3	3
SKIN	Type IIa hypersensitivity →	+0.780	+0.009	.002	.003	3	3
SKIN	Type II hypersensitivity →	+0.780	+0.009	.002	.003	3	3
LUNG_NSCLC_LUAD	Intracellular lipid transport →	+0.054	+0.007	.001	.008	3	3
CNS	Protein localization to cell surface →	+0.064	+0.023	<.001	.001	3	3
BREAST	Response to activity →	+0.081	+0.003	.005	.006	3	3

Each partner links to its Q-omics profile. Showing the 6 strongest of 657 associations by consensus.

Antibody-dependent cellular cytotoxicity by CD209 expression — SKIN

Explore this box plot interactively →